OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
A significant number of new chemical entities under development are poorly water-soluble drugs generally characterized by an insufficient and low bioavailability [1,2]. Currently, >40% of the new drug candidates are speculated to be highly lipophilic and thus poorly bioavailable [3].
